Codes, payment rates, coverage policy, and whose budget it comes from — stress urinary incontinence

1. Summary

The single HCPCS Level II code covering this domain's prescription home devices is E0740, and Medicare's own coding contractor states the code was written to require a device that both stimulates and monitors — a monitoring-only device does not qualify [5]. That contractor has also announced that every product currently on the PDAC (Pricing, Data Analysis and Coding contractor) Product Classification List under E0740 will undergo a code re-review, which the prior version of this report did not record [5]. Medicare's coverage rule for E0740, NCD 230.8, conditions coverage on cognitively intact patients first failing a documented four-week trial of pelvic muscle exercise, a threshold unchanged since its 2006 reissue [1][2]. The two commercial payers read this pass diverge from Medicare and from each other: Aetna states a coverage position for intravaginal pelvic floor electrical stimulation with no four-week-failure precondition, no home-versus-office distinction, and no cross-reference to NCD 230.8 [6]; Cigna removed pelvic floor electrical stimulation from its home electrical- stimulation policy altogether in January 2025, and E0740 appears nowhere in that policy's current September 2026 version [8]. On payment, the prior version recorded that no CMS amount for E0740 could be located. That gap is now partly closed from a different source class: CMS's own Medicare DME utilization release reports, for data year 2024, a national average allowed amount of $57.89 and an average Medicare payment of $42.94 for E0740, across 689 beneficiaries, 4,130 supplier services and 28 suppliers nationally, with the code flagged as rentable [7]. These are realized averages, not the DMEPOS (durable medical equipment, prosthetics, orthotics and supplies) fee-schedule amount, which remains unretrieved.

2. What Changed

• New: The PDAC's E0740 article states that "All products currently listed on the PDAC Product Classification List with HCPCS code E0740 will undergo a code re-review," and that manufacturers of affected products will be notified to resubmit product information. The article states no deadline or effective date for that re-review. The prior version of this report read the same article but did not record the re-review [5] [single-source].
• Closed, a residual the prior version left open. v1 recorded Aetna's apparent absence of a PME-failure precondition as "what was retrieved, not confirmed as a substantive policy difference," and noted a fuller read might find PME language elsewhere in the bulletin. A targeted re-read this pass asked that question directly: the policy does not state a prior failed pelvic muscle exercise requirement or any minimum trial duration, does not differentiate home-use from in-office devices, and contains no reference to NCD 230.8 [6] [single-source].
• New payer, and a reversal of v1's "not retrieved". v1 recorded the Cigna policy as **not retrieved** because its PDF "did not extract cleanly through WebFetch." The PDF was retrieved and extracted in full this pass. Cigna Medical Coverage Policy 0160 removed "pelvic floor electrical stimulation" from its policy statement in the 1/15/2025 Annual Review/Focused Review, and the code E0740 appears nowhere in the current version, effective 9/15/2026 [8].
• New source class, partly closing v1's payment gap. v1 searched for a DMEPOS payment amount and recorded "not found." CMS's Medicare DME utilization release — a different release from the fee schedule, and not queried by v1 — carries realized national figures for E0740 [7].

3. Details

HCPCS coding — E0740, what it covers, and a re-review in progress

The PDAC's own scope determination is unchanged and remains single-source: "HCPCS code E0740 is intended to describe non-implantable pelvic floor electrical stimulators with integrated monitoring capabilities," and "devices limited to only muscle monitoring capability (i.e., without electrical muscle stimulation capability) were not intended to be included in E0740" [5] [single-source]. Read together those two sentences set the code's boundary from both sides: a device must stimulate to be in, and the presence of integrated monitoring is the code's defining feature rather than an optional extra.

New this pass, and not recorded in v1: the same article states that "All products currently listed on the PDAC Product Classification List with HCPCS code E0740 will undergo a code re-review," and that "Manufacturers of affected products will be notified to submit product information to the PDAC" [5] [single-source]. The article names no deadline, no effective date, and no stated consequence for a product that fails the re-review; coding for products within DME contractor jurisdiction "will be assigned as part of the coding review process" [5] [single-source]. The article's own last-updated date is 2023-11-10 [5].

One sentence in the same article bears directly on how the two halves of such a device are paid: "Medicare does not provide reimbursement for devices used to provide monitoring functions," with biofeedback-only devices referred to the appropriate A/B MAC (Medicare administrative contractor) [5] [single-source]. The code therefore requires integrated monitoring for eligibility while Medicare separately declines to pay for monitoring as a function.

Medicare coverage policy — NCD 230.8

Unchanged from v1 and carried forward without re-retrieval this pass: NCD 230.8 conditions coverage of a non-implantable pelvic floor electrical stimulator on a cognitively intact patient who has failed a documented four-week trial of pelvic muscle exercise training, for stress and/or urge urinary incontinence [1][2] [single-source]. CMS's 2000 national coverage analysis (CAG-00021N) preceded it [3][4] [single-source]. Readers should treat the four CMS pages as one organization rather than four independent sources.

Commercial payer coverage — two payers, two different divergences from Medicare

Aetna — Clinical Policy Bulletin No. 0223, "Urinary Incontinence," states that Aetna "considers intravaginal electrical stimulation of the pelvic floor medically necessary for women with stress, urgency or mixed urinary incontinence" [6] [single-source]. A targeted re-read this pass, asking specifically the questions v1 left open, returned three findings, each of which is an absence in the retrieved document rather than an affirmative statement: the policy does not specify a prior failed pelvic muscle exercise requirement or a minimum trial duration; it does not differentiate home-use from in-office devices, covering pelvic floor electrical stimulation generally without explicitly addressing home devices; and it contains no reference to Medicare NCD 230.8 [6] [single-source]. The bulletin refers biofeedback to Aetna's separate CPB 0132 [6]. No last-review or revision date is stated on the retrieved page [6].

An absence in a retrieved document is weaker evidence than a statement in one. What is established is that a full-document question was asked and the language was not found; what is not established is that Aetna would pay for a home device without a documented exercise trial, which is an adjudication question no policy page answers.

Cigna — Medical Coverage Policy 0160, "Electrical Stimulation Therapy and Devices in a Home Setting," effective 9/15/2026, next review 9/15/2027, does not mention HCPCS E0740 anywhere in its 77 pages [8]. Its own revision history records that in the Annual Review/Focused Review dated 1/15/2025, Cigna "Removed the following therapies/devices from the policy statement: auricular electroacupuncture; cranial electrical stimulation; pelvic floor electrical stimulation; transcutaneous electrical joint stimulation" [8]. The same revision separately added a different list of therapies to the noncoverage policy statement [8].

What this establishes: as of January 2025, pelvic floor electrical stimulation is not addressed by Cigna's home electrical-stimulation policy. What it does not establish, and must not be read as establishing: where the topic went, or what Cigna's current coverage position is. Policy 0160 names a related coverage resource titled "Incontinence and Constipation," which was not retrieved this pass. A secondary summary encountered in search suggested Cigna requires prior authorization on criteria that track the NCD 230.8 language; that summary is not cited as a finding here because the underlying policy document was not retrieved, and a search-result paraphrase of a payer policy is not a payer policy.

Payment — realized Medicare amounts for E0740, and the denominator behind them

v1 recorded that no CMS payment amount for E0740 had been located. CMS's "Medicare Durable Medical Equipment, Devices & Supplies — by Geography and Service" release, data year 2024, carries the national row for E0740 [7]:

Three readings matter and are kept separate from the numbers themselves.

These are realized averages across paid claims, not the DMEPOS fee-schedule amount. The fee schedule sets an allowable ceiling; what CMS actually allowed on average in 2024 was $57.89, and what it actually paid was $42.94, the gap between allowed and paid being consistent with ordinary beneficiary cost-sharing. A fee-schedule figure and a realized average are different quantities and a reader must not substitute one for the other. The fee-schedule amount itself remains not retrieved [7].

The beneficiary count is the denominator, and it is much smaller than the service count. 689 beneficiaries nationally received this code in Medicare FFS (fee-for-service) in 2024, against 4,130 services — a ratio that the Suplr_Rentl_Ind: Y flag explains, since a rentable item bills repeatedly for one patient. Any sizing that reads 4,130 as a count of devices or of patients overstates the population by roughly sixfold [7] [inference — see §5].

Twenty-eight suppliers nationally bill the code, against 553 referring providers [7]. That is a narrow supply channel, and it is a fact about the existing channel, not a forecast about a new entrant's.

Whose budget

Unchanged from v1 in substance: the device is billed to whichever DME benefit administers the patient's coverage — Medicare Part B (Medicare Part B)'s DME benefit under NCD 230.8, or a commercial payer's own DME-type benefit [2][6]. E0740 is assigned and its coding scope adjudicated by the PDAC and processed through a regional DME MAC [5]. What is added this pass is that the Medicare side of that budget is, at present, very small in absolute terms: 689 beneficiaries at an average $42.94 of Medicare payment is on the order of $30,000 of annual Medicare payment nationally for the code [7] [inference — see §5].

4. Sources

[1] National Coverage Determination 230.8, "Non-Implantable Pelvic Floor Electrical Stimulator," version 1 — CMS Medicare Coverage Database (effective 2001-04-01; accessed 2026-09-01, carried forward unretrieved 2026-09-19). NCD 230.8 — https://www.cms.gov/medicare-coverage-database/view/ncd.aspx?ncdid=231&ncdver=1 [payer-policy] [2] National Coverage Determination 230.8, "Non-Implantable Pelvic Floor Electrical Stimulator," version 2 (current) — CMS Medicare Coverage Database (effective 2006-06-19; accessed 2026-09-01, carried forward unretrieved 2026-09-19). NCD 230.8 — https://www.cms.gov/medicare-coverage-database/view/ncd.aspx?ncdid=231&ncdver=2 [payer-policy] [3] National Coverage Analysis Tracking Sheet, CAG-00021N, "Pelvic Floor Electrical Stimulation for Urinary Incontinence" — CMS Medicare Coverage Database (decision memo published 2000-10-05; accessed 2026-09-01, carried forward unretrieved 2026-09-19). NCA CAG-00021N, the analysis underlying NCD 230.8 — https://www.cms.gov/medicare-coverage-database/view/ncacal-tracking-sheet.aspx?ncaid=61 [payer-policy] [4] National Coverage Analysis detail/search view for CAG-00021N cross-referenced to HCPCS E0740 — CMS Medicare Coverage Database (decision memo dated 2000-10-05; accessed 2026-09-01, carried forward unretrieved 2026-09-19). HCPCS E0740; NCA CAG-00021N — https://www.cms.gov/medicare-coverage-database/view/nca.aspx?ncaid=61&SearchType=Advanced&CptHcpcsCode=E0740 [payer-policy] [5] "PDAC Code Review - E0740 Non-Implantable Pelvic Floor Electrical Stimulator" — Noridian Healthcare Solutions, JD DME (last updated 2023-11-10; accessed 2026-09-19). HCPCS E0740 — https://med.noridianmedicare.com/web/jddme/policies/dmd-articles/pdac-code-review-e0740-non-implantable-pelvic-floor-electrical-stimulator [payer-policy] [6] Clinical Policy Bulletin No. 0223, "Urinary Incontinence" — Aetna (no date stated on the retrieved page; accessed 2026-09-19). Aetna CPB No. 0223; HCPCS E0740 — https://www.aetna.com/cpb/medical/data/200_299/0223.html [payer-policy] [7] "Medicare Durable Medical Equipment, Devices & Supplies — by Geography and Service," data year 2024 (release RY2026, catalog entry modified 2026-07-23; accessed 2026-09-19). data.cms.gov dataset 27c150fd-8578-43b1-bba5-6388987e32af, file mup_dme_ry26_p05_v10_dy24_geor.csv; HCPCS E0740, row Rfrg_Prvdr_Geo_Lvl=National — https://data.cms.gov/data-api/v1/dataset/27c150fd-8578-43b1-bba5-6388987e32af/data [federal-registry] [8] Medical Coverage Policy 0160, "Electrical Stimulation Therapy and Devices in a Home Setting" — Cigna (effective 2026-09-15, next review 2027-09-15 per the document's own header; revision history entry dated 2025-01-15; accessed 2026-09-19). Cigna Coverage Policy Number 0160 — the payer's own policy number, which is not a registry identifier in this vocabulary; no HCPCS code is cited on this line because the finding is that the code does not appear in the document [no-identifier] — https://static.cigna.com/assets/chcp/pdf/coveragePolicies/medical/mm_0160_coveragepositioncriteria_electrical_stimulators.pdf [payer-policy]

5. Sourcing & Gaps

Well established: The E0740 national utilization and payment figures in §3 come from CMS's own release and are a federal registry record, not an estimate [7]. The Cigna revision-history fact — that pelvic floor electrical stimulation was removed from policy 0160 on 1/15/2025 and is absent from the current version — rests on the policy document's own printed revision table, read in full [8].

Thin: Everything about NCD 230.8 rests on CMS's own documents only, four pages from one organization, and is carried forward from v1 without re-retrieval this pass [1][2][3][4]. The PDAC's scope determination and the newly recorded code re-review rest on that contractor's single article [5]. Every Aetna finding rests on one page, and three of the four are absences in that page rather than statements in it [6] — a weaker form of evidence, flagged as such in §3.

Rescoped from class 3: None. This pass asked only registry and coverage-policy questions.

Out of scope: CPT-coded billing (RTM 98977/98980/98981 and the PT/biofeedback visit-code families) — AMA-licensed and excluded by the manifest's scope note. State Medicaid schedules. Non-US coverage regimes.

Not searched vs. not found:

• The DMEPOS fee-schedule amount for E0740 is still not retrieved. This pass did not query the CMS fee-schedule bulk files or the Fee Schedule Look-Up Tool. The realized averages in [7] do not substitute for it and are not presented as it.
• Cigna's current position on pelvic floor electrical stimulation is not found. Policy 0160 establishes only that the topic left that policy. The related "Incontinence and Constipation" coverage resource was not retrieved, and the search-result paraphrase of it is deliberately not cited as a finding.
• UnitedHealthcare and Anthem policies were not searched this pass.
• The E0740 code re-review's outcome and timing are not found — the article names no deadline and no consequence, and no later PDAC notice was searched for.
• Whether this specific device — intravaginal, EMG (electromyography)-sensing, app-linked — codes to E0740 remains not established. The PDAC's scope language is favourable on its face, since the device both stimulates and monitors, but a coding-scope article is not a coding verification, and only a PDAC submission produces one. This is the same gap REQ-0019 was raised against and it is narrowed, not closed.

[inference] Two, both in §3 and both marked there. (a) That reading 4,130 services as devices or patients overstates the population roughly sixfold — this is arithmetic over the released service and beneficiary counts plus the rental flag, not a statement CMS makes. (b) That ~689 beneficiaries at ~$42.94 implies on the order of $30,000 of annual national Medicare payment for the code — again arithmetic over [7], and a floor on a Medicare-FFS-only figure, not a market size.

6. Claim Candidates